About Halyard Health
Halyard Health, Inc. seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. The Medical Devices segment provides a portfolio of product offerings focused on pain management and respiratory and digestive health. The S&IP segment's product portfolio includes sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves. The S&IP segment is also a provider of education to prevent healthcare-associated infections. The Medical Devices segment provides a portfolio of product offerings focused on pain management and respiratory and digestive health. Its products include QUICK CHECK, SMART-FOLD, POWERGUARD, MICROCOOL and FLUIDSHIELD.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Instruments & Supplies
- Sub-Industry: N/A
- Exchange: NYSE
- Symbol: HYH
- Previous Close: $40.99
- 50 Day Moving Average: $38.24
- 200 Day Moving Average: $36.15
- 52-Week Range: $24.60 - $41.78
- Trailing P/E Ratio: 43.65
- Foreward P/E Ratio: 21.80
- P/E Growth: -7.30
- Market Cap: $1.91B
- Outstanding Shares: 46,700,000
- Beta: 1.87
- Net Margins: 2.80%
- Return on Equity: 8.63%
- Return on Assets: 4.54%
Companies Related to Halyard Health:
- Debt-to-Equity Ratio: 0.54%
- Current Ratio: 1.95%
- Quick Ratio: 0.99%
What is Halyard Health's stock symbol?
Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."
Where is Halyard Health's stock going? Where will Halyard Health's stock price be in 2017?
4 analysts have issued 12-month price targets for Halyard Health's shares. Their forecasts range from $35.00 to $38.00. On average, they anticipate Halyard Health's share price to reach $37.00 in the next year.
When will Halyard Health announce their earnings?
Halyard Health is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.
Who owns Halyard Health stock?
Halyard Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (4.73%), State Street Corp (3.33%), Hodges Capital Management Inc. (0.98%), Loomis Sayles & Co. L P (0.81%), Employees Retirement System of Texas (0.49%) and CNH Partners LLC (0.36%). Company insiders that own Halyard Health stock include Robert E Abernathy and Steven E Voskuil.
Who sold Halyard Health stock? Who is selling Halyard Health stock?
Halyard Health's stock was sold by a variety of institutional investors in the last quarter, including CNH Partners LLC, State Street Corp, Two Sigma Investments LP, Oxford Asset Management, Thrivent Financial for Lutherans, Tudor Investment Corp Et Al, Federated Investors Inc. PA and Continental Advisors LLC.
Who bought Halyard Health stock? Who is buying Halyard Health stock?
Halyard Health's stock was acquired by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Russell Investments Group Ltd., Cutter & CO Brokerage Inc., Systematic Financial Management LP, Guggenheim Capital LLC, Allianz Asset Management AG, Folger Hill Asset Management LP and Blenheim Capital Management BV. Company insiders that have bought Halyard Health stock in the last two years include Robert E Abernathy and Steven E Voskuil.
How do I buy Halyard Health stock?
Shares of Halyard Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Halyard Health stock cost?
One share of Halyard Health stock can currently be purchased for approximately $41.42.